CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Ustekinumab for the treatment of refractory pediatric Crohn’s disease: a single-center experience
Alexandra Cohen, Najma Ahmed, Ana Sant’Anna
Intest Res. 2021;19(2):217-224.   Published online April 22, 2020
DOI: https://doi.org/10.5217/ir.2019.09164

Excel Download

Ustekinumab for the treatment of refractory pediatric Crohn’s disease: a single-center experience
Intestinal Research. 2021;19(2):217-224   Crossref logo
Link1 Link2 Link3

A229 USTEKINUMAB FOR THE TREATMENT OF REFRACTORY PEDIATRIC CROHN’S DISEASE: A SINGLE CENTRE EXPERIENCE
Journal of the Canadian Association of Gastroenterology. 2020;3(Supplement_1):104-106   Crossref logo
Link1 Link2

Ustekinumab success in refractory Crohn’s disease
Springer Healthcare News. 2012;1(1):   Crossref logo
Link1 Link2 Link3

Efficacy and tolerability of methotrexate therapy for refractory Crohn’s disease: a large single-centre experience
Alimentary Pharmacology & Therapeutics. 2011;35(2):284-291   Crossref logo
Link1 Link2

Tu1713 - Clinical Outcomes with Ustekinumab as Recue Treatment in Therapy-Refractory or -Intolerant Ulcerative Colitis: Real Worl Experience in a Large Single Center Cohort
Gastroenterology. 2018;154(6):S-997   Crossref logo
Link1 Link2

Tu1710 – Ustekinumab to Treat Pediatric Patients with Crohn's Disease: A Single Center Experience
Gastroenterology. 2019;156(6):S-1094   Crossref logo
Link1 Link2

P344 Effectiveness of ustekinumab in refractory Crohn’s disease: A real-life experience in a tertiary referral centre
Journal of Crohn's and Colitis. 2020;14(Supplement_1):S330-S330   Crossref logo
Link1 Link2

Infliximab treatment in refractory vascular Behcet’s disease: A single-center experience
Vascular. 2020;28(6):829-833   Crossref logo
Link1 Link2 Link3

Safety and steroid-sparing experience using infliximab for Crohn’s disease at a pediatric inflammatory bowel disease center
Journal of Pediatric Surgery. 2004;39(5):785-786   Crossref logo
Link1 Link2

Cost of Refractory Crohn’s Disease Before and After Ustekinumab Utilization
Journal of the Canadian Association of Gastroenterology. 2019;   Crossref logo
Link1